sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 05/07/2011
PIL Aprovel 150mg film coated tablets (sanofi-aventis)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 24/08/2009 and displayed until 05/07/2011
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 05/09/2008 and displayed until 24/08/2009
Reasons for adding or updating:
  • Addition of separate PILs covering individual presentations
Updated on 11/05/2004 and displayed until 05/09/2008
Reasons for adding or updating:
  • PIL Product / presentation discontinued
  • Change to side-effects
Updated on 16/10/2002 and displayed until 11/05/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   irbesartan